Braveheart Bio, Inc. files its Q3 report, detailing financial performance and operational updates in the pharmaceutical preparations sector.
| Name | Braveheart Bio, Inc. |
|---|---|
| CIK | 0002131524 |
| Tickers | BRVE |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 992981994 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (415) 707-6312 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Braveheart Bio, Inc. files its Q3 report, detailing financial performance and operational updates in the pharmaceutical preparations sector.
Jiangsu Hengrui Pharmaceuticals has acquired an 8.2% stake in Braveheart Bio, marking a significant investment in the pharmaceutical preparations sector.
Braveheart Bio, Inc. reports promising data from a Phase 2 study of HRS/BHB-1893, showing significant improvements in patients with obstructive hypertrophic cardiomyopathy.
FMR LLC has reported an 8.2% stake in Braveheart Bio, Inc., indicating strong institutional interest in the pharmaceutical sector.
53 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001628280-26-074219 | 005-95888 | 261561969 | 34 | 7807 | |||
| 2026-11-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-462144 | 005-95888 | 261555485 | 34 | 11809 | |||
| 2026-11-10 | 10-Q | 10-Q | 0001628280-26-072709 | 001-43432 | 261540316 | 34 | 7046694 | 1 | 1 | |
| 2026-11-10 | 8-K | 8-K | 2.02,9.01 | 0001628280-26-072702 | 001-43432 | 261540236 | 34 | 340146 | 1 | 1 |
| 2026-11-09 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-124063 | 005-95888 | 261533615 | 34 | 7347 | |||
| 2026-11-06 | 8-K | 8-K | 7.01,9.01 | 0001628280-26-071586 | 001-43432 | 261531464 | 34 | 302504 | 1 | 1 |
| 2026-11-05 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002715 | 005-95888 | 261526119 | 34 | 11647 | |||
| 2026-09-10 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0000947871-26-000860 | 005-95888 | 261371906 | 34 | 33533 | |||
| 2026-09-08 | 10-Q | 10-Q | 0001628280-26-060905 | 001-43432 | 261365128 | 34 | 6197181 | 1 | 1 | |
| 2026-09-08 | 8-K | 8-K | 2.02,9.01 | 0001628280-26-060904 | 001-43432 | 261365114 | 34 | 367400 | 1 | 1 |
| 2026-08-18 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0000947871-26-000814 | 005-95888 | 261291714 | 34 | 34418 | |||
| 2026-08-14 | 3 | xslF345X06/form3-08142026_090827.xml | 0002003663-26-000005 | 5414 | ||||||
| 2026-08-14 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0001889476-26-000004 | 005-95888 | 261283241 | 34 | 38180 | |||
| 2026-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001231919-26-000910 | 005-95888 | 261282283 | 34 | 30051 | |||
| 2026-08-11 | 4 | xslF345X06/form4-08112026_090855.xml | 0001231919-26-000859 | 15564 | ||||||
| 2026-08-11 | 4 | xslF345X06/ownership.xml | 0000947871-26-000783 | 13334 | ||||||
| 2026-08-11 | 4 | xslF345X06/ownership.xml | 0000947871-26-000782 | 17211 | ||||||
| 2026-08-10 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-093140 | 8243 | ||||||
| 2026-08-07 | 4 | 4 | 0001193125-26-340528 | 21384 | ||||||
| 2026-08-07 | 4 | FORM 4 | 0001470831-26-000804 | 8969 | ||||||
| 2026-08-07 | 4 | FORM 4 | 0001470831-26-000803 | 5583 | ||||||
| 2026-08-07 | 4 | FORM 4 | 0001470831-26-000802 | 6032 | ||||||
| 2026-08-07 | 4 | FORM 4 | 0001470831-26-000801 | 8186 | ||||||
| 2026-08-07 | 4 | FORM 4 | 0001470831-26-000800 | 8898 | ||||||
| 2026-08-07 | 4 | FORM 4 | 0001470831-26-000799 | 7026 | ||||||
| 2026-08-07 | 4 | FORM 4 | 0001470831-26-000798 | 9707 | ||||||
| 2026-08-07 | 4 | FORM 4 | 0001470831-26-000797 | 5624 | ||||||
| 2026-08-07 | 4 | FORM 4 | 0001470831-26-000796 | 6987 | ||||||
| 2026-08-07 | 8-K | 8-K | 5.03,9.01 | 0001628280-26-054842 | 001-43432 | 261254163 | 34 | 221223 | ||
| 2026-08-06 | S-8 | S-8 | 0001628280-26-054371 | 333-298060 | 261249579 | 33 | 252111 | 1 | 1 | |
| 2026-08-06 | 424B4 | S-1/A | 0001628280-26-054354 | 333-297456 | 261249440 | 33 | 12251150 | |||
| 2026-08-06 | CERT | BRVE_8A_Cert_2131524.pdf | 0001354457-26-000761 | 001-43432 | 261246205 | 34 | 181044 | |||
| 2026-08-06 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-091481 | 5545 | ||||||
| 2026-08-05 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-002550 | 333-297456 | 261245641 | 33 | 1778 | ||
| 2026-08-05 | 3 | xslF345X06/ownership.xml | 0000947871-26-000749 | 9101 | ||||||
| 2026-08-05 | 3 | xslF345X06/form3-08062026_010811.xml | 0001231919-26-000833 | 21765 | ||||||
| 2026-08-05 | 3 | 3 | 0001193125-26-336143 | 14740 | ||||||
| 2026-08-05 | 3 | FORM 3 | 0001470831-26-000780 | 10005 | ||||||
| 2026-08-05 | 3 | FORM 3 | 0001470831-26-000779 | 9265 | ||||||
| 2026-08-05 | 3 | FORM 3 | 0001470831-26-000778 | 7455 | ||||||
| 2026-08-05 | 3 | FORM 3 | 0001470831-26-000777 | 7492 | ||||||
| 2026-08-05 | 3 | FORM 3 | 0001470831-26-000776 | 9532 | ||||||
| 2026-08-05 | 3 | FORM 3 | 0001470831-26-000775 | 11463 | ||||||
| 2026-08-05 | 3 | FORM 3 | 0001470831-26-000774 | 10767 | ||||||
| 2026-08-05 | 3 | FORM 3 | 0001470831-26-000773 | 7414 | ||||||
| 2026-08-05 | 3 | FORM 3 | 0001470831-26-000772 | 9950 | ||||||
| 2026-08-05 | 3 | FORM 3 | 0001470831-26-000771 | 10288 | ||||||
| 2026-08-05 | S-1MEF | S-1MEF | 0001628280-26-053690 | 333-298034 | 261245447 | 33 | 213133 | 1 | 1 | |
| 2026-08-03 | 8-A12B | 8-A12B | 0001628280-26-051795 | 001-43432 | 261232717 | 34 | 20379 | |||
| 2026-07-30 | S-1/A | S-1/A | 0001628280-26-050756 | 333-297456 | 261219982 | 33 | 14335834 | 1 | 1 | |
| 2026-07-15 | S-1 | S-1 | 0001628280-26-048213 | 333-297456 | 261175297 | 33 | 14518200 | 1 | 1 | |
| 2026-06-08 | DRS/A | filename1.htm | 0001628279-26-000717 | 377-09309 | 261073622 | 33 | 12518362 | |||
| 2026-04-29 | DRS | filename1.htm | 0001628279-26-000549 | 377-09309 | 26917440 | 33 | 11902784 |
One latest value per concept from companyfacts (141 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 89.87M | 2026-11-06 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 32,304.79 | 2026-08-06 | S-8 | 2026-08-06 | 0001628280-26-054371 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 32,304.79 | 2026-08-06 | S-8 | 2026-08-06 | 0001628280-26-054371 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 233.92M | 2026-08-06 | S-8 | 2026-08-06 | 0001628280-26-054371 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-08-06 | S-8 | 2026-08-06 | 0001628280-26-054371 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-08-05 | S-1MEF | 2026-08-05 | 0001628280-26-053690 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 1.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 8.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 732,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -718,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 620.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings | Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings | USD | 3.62M | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 2.79M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 35.50M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 13.47M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | Assets | Assets | USD | 514.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 359.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 501.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 121.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 503.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 121.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 32.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 14.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 500.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 89.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 82.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 8,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -56.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 213.52M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest | DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent | DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent | USD | 228.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent | DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent | USD | 154.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | DebtSecuritiesAvailableForSaleExcludingAccruedInterest | DebtSecuritiesAvailableForSaleExcludingAccruedInterest | USD | 382.23M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent | DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent | USD | 227.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent | DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent | USD | 154.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense | Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense | USD | 6.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent | Deferred Compensation Share-based Arrangements, Liability, Classified, Noncurrent | USD | 100,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | DeferredCosts | Deferred Costs, Noncurrent | USD | 2.81M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-09-08 | 0001628280-26-060905 | |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 8,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -2.66 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -2.66 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 2.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 45.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 21.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 1.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | 7.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 28,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 10.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | InterestReceivableCurrent | Interest Receivable, Current | USD | 1.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | InvestmentIncomeAmortizationOfDiscount | Investment Income, Amortization of Discount | USD | 496,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 5.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | LesseeOperatingLeaseDiscountRate | Lessee, Operating Lease, Discount Rate | pure | 0.077 | 2026-01-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 538,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 433,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 105,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 23,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | Liabilities | Liabilities | USD | 16.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 514.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 16.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 464.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -385.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -46.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -55.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -59.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | -59.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 5.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 61.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -61.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 300,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 515,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 415,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 100,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 400,000 | 2026-01-01 | 2026-01-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 510,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 30,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 98,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent | USD | -718,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 6.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 75,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | OtherNonoperatingIncome | Other Nonoperating Income | USD | 3,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-09-08 | 0001628280-26-060905 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -55,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | PaymentsForRepurchaseOfEquity | Payments for Repurchase of Equity | USD | 8,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 4.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 382.45M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | PaymentsToAcquireInProcessResearchAndDevelopment | Payments to Acquire in Process Research and Development | USD | 3.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | PaymentsToAcquireLongtermInvestments | Payments to Acquire Long-term Investments | USD | 154.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 28,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | PaymentsToAcquireShortTermInvestments | Payments to Acquire Short-term Investments | USD | 227.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | PreferredStockConvertibleSharesIssuable | PreferredStockConvertibleSharesIssuable | shares | 49.66M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-09-08 | 0001628280-26-060905 | |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 10.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 409.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock | Proceeds from Issuance of Redeemable Convertible Preferred Stock | USD | 59.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 20,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | RedeemablePreferredStockDividends | Redeemable Preferred Stock Dividends | USD | 3.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff | Research and Development Asset Acquired Other than Through Business Combination, Written-off | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost | Research and Development Expense (Excluding Acquired in Process Cost) | USD | 39.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -122.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 795,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 5.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 433,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 107,397 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 16.17 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 213,230 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 5.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 8.56 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 48.23M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 5.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 12.13 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | shares | 10,702 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 1.71 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 12.43 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 497.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.228 | 2026-07-29 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | StockIssued1 | Stock Issued | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities | Stock Issued During Period, Shares, Conversion of Convertible Securities | shares | 49.66M | 2026-08-06 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 213.52M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 404.41M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | USD | 1,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 217.50M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-09-08 | 0001628280-26-060905 | |
| us-gaap | TemporaryEquityRedemptionPricePerShare | Temporary Equity, Redemption Price Per Share | USD/shares | 1 | 2026-04-24 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 217.50M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-09-08 | 0001628280-26-060905 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 217.50M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-09-08 | 0001628280-26-060905 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | TemporaryEquityStockIssuedDuringPeriodValueNewIssues | Temporary Equity, Stock Issued During Period, Value, New Issues | USD | 60.00M | 2026-04-24 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 | |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 22.29M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation | Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation | shares | 8.59M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | WeightedAverageNumberOfSharesIssuedBasic | Weighted Average Number of Shares Issued, Basic | shares | 30.87M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 22.29M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001628280-26-072709 |